Citation: M. Soukop, ADVERSE REACTIONS TO ANTINAUSEANTS IN COMMON USE IN THE UK, Adverse drug reactions and toxicological reviews, 17(2-3), 1998, pp. 91-113
Authors:
EATOCK MM
ANTHONY DA
WILSON P
SOUKOP M
SMITH M
EVANS TRJ
Citation: Mm. Eatock et al., PRELIMINARY-RESULTS OF A DOSE-FINDING STUDY OF TOMUDEX WITH CISPLATINAND EPIRUBICIN AS FIRST-LINE THERAPY FOR METASTATIC OR UNRESECTABLE GASTRIC AND ESOPHAGEAL ADENOCARCINOMA, Annals of oncology, 9, 1998, pp. 235-235
Authors:
HAYNES BP
GRIMSHAW RM
GRIGGS LJ
HARDCASTLE I
NUTLEY BP
JARMAN M
JOHNSTON SRD
TWELVES CJR
SOUKOP M
REA DW
HOWELL A
JONES A
COOMBES RC
Citation: Bp. Haynes et al., PHARMACOKINETIOS OF IDOXIFENE AND TAMOXIFEN IN A RANDOMIZED PHASE-II TRIAL IN BREAST-CANCER PATIENTS WHO HAVE RELAPSED ON TAMOXIFEN, Annals of oncology, 9, 1998, pp. 679-679
Authors:
CASSIDY J
PAUL J
SOUKOP M
HABESHAW T
REED NS
PARKIN D
KAYE SB
Citation: J. Cassidy et al., CLINICAL-TRIALS OF NIMODIPINE AS A POTENTIAL NEUROPROTECTOR IN OVARIAN-CANCER PATIENTS TREATED WITH CISPLATIN, Cancer chemotherapy and pharmacology, 41(2), 1998, pp. 161-166
Authors:
LOPEZ RI
PAUL J
ATKINSON R
SOUKOP M
KITCHENER H
FULLERTON W
DUNCAN I
KENNEDY J
DAVIS J
MACLEAN A
CASSIDY J
PYPER E
KAYE SB
Citation: Ri. Lopez et al., PROGNOSTIC FACTOR-ANALYSIS, FOR PATIENTS WITH NO EVIDENCE OF DISEASE AFTER INITIAL CHEMOTHERAPY FOR ADVANCED EPITHELIAL OVARIAN-CARCINOMA, International journal of gynecological cancer, 6(1), 1996, pp. 8-14
Authors:
DALY M
COWIE VJ
DAVIS JA
HABESHAW T
JUNOR E
PAUL J
PYPER E
REED NS
SOUKOP M
YOSEF H
SYMONDS RP
Citation: M. Daly et al., A SHORT AND INTENSIVE SINGLE-AGENT CISPLATIN REGIMEN FOR RECURRENT CARCINOMA OF THE UTERINE CERVIX, International journal of gynecological cancer, 6(1), 1996, pp. 61-67
Authors:
HUGHES MJ
KERR DJ
CASSIDY J
SOUKOP M
MCGREGOR K
BLACKBURN N
YOSEF H
KAYE SB
Citation: Mj. Hughes et al., A PILOT-STUDY OF COMBINATION THERAPY WITH INTERFERON-ALPHA-2A AND 5-FLUOROURACIL IN METASTATIC CARCINOID AND MALIGNANT ENDOCRINE PANCREATICTUMORS, Annals of oncology, 7(2), 1996, pp. 208-210
Authors:
KAYE SB
PAUL J
CASSIDY J
LEWIS CR
DUNCAN ID
GORDON HK
KITCHENER HC
CRUICKSHANK DJ
ATKINSON RJ
SOUKOP M
RANKIN EM
DAVIS JA
REED NS
CRAWFORD SM
MACLEAN A
PARKIN D
SARKAR TK
KENNEDY J
SYMONDS RP
Citation: Sb. Kaye et al., MATURE RESULTS OF A RANDOMIZED TRIAL OF 2 DOSES OF CISPLATIN FOR THE TREATMENT OF OVARIAN-CANCER, Journal of clinical oncology, 14(7), 1996, pp. 2113-2119
Authors:
EATOCK MM
CARLIN W
DUNLOP DJ
SOUKOP M
WATSON DG
Citation: Mm. Eatock et al., BIOAVAILABILITY OF SUBCUTANEOUS 5-FLUOROURACIL - A CASE-REPORT, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 110-112
Authors:
EATOCK M
COOK G
FRANKLIN IM
TANSEY P
SOUKOP M
DUNLOP D
Citation: M. Eatock et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) RESCUE FOLLOWING HIGH-DOSE CHEMOTHERAPY IN BREAST-CANCER - SATISFACTORY EARLY HEMATOPOIETIC RECONSTITUTION, British Journal of Cancer, 73(8), 1996, pp. 25-25
Authors:
BRANKIN E
GALLACHER SJ
BESSENT R
SOUKOP M
BOYLE IT
Citation: E. Brankin et al., BONE-MINERAL DENSITY IN ADULTS WITH LYMPHOMA AND THE EFFECTS OF TREATMENT, British Journal of Cancer, 73(8), 1996, pp. 112-112
Authors:
RUSTIN GJS
CRAWFORD SM
COLEMAN RE
LAMBERT J
LEDERMANN JA
SOUKOP M
KARP S
PHILLIPS RH
HABBOUBI N
MEELY K
Citation: Gjs. Rustin et al., TRIAL OF ORAL HEXALEN FOR RELAPSED OVARIAN-CARCINOMA [OV CA] - COMPARISON OF CA125 AND EORTC RESPONSE DEFINITIONS/, European journal of cancer, 31A, 1995, pp. 513-513
Authors:
TYRRELL CT
BRUNING PF
MAYLEVIN F
ROSE C
MAURIAC L
SOUKOP M
FORD JM
Citation: Ct. Tyrrell et al., PAMIDRONATE INFUSIONS AS SINGLE-AGENT THERAPY FOR BONE METASTASES - APHASE-II TRIAL IN PATIENTS WITH BREAST-CANCER, European journal of cancer, 31A(12), 1995, pp. 1976-1980
Authors:
ADAMS M
SOUKOP M
BARLEY V
YOSEF H
ANDERSON N
BOESEN E
TRASK CW
RUFENACHT E
DEBRUIJN KM
Citation: M. Adams et al., TROPISETRON ALONE OR IN COMBINATION WITH DEXAMETHASONE FOR THE PREVENTION AND TREATMENT OF EMESIS INDUCED BY NON-CISPLATIN CHEMOTHERAPY - ARANDOMIZED TRIAL, Anti-cancer drugs, 6(4), 1995, pp. 514-521
Authors:
GOEDHALS L
JORDAAN JP
KAYE SB
ARMAND JP
VEENHOF CHN
FALKSON G
SOUKOP M
SCHNEIDER M
OBERLING F
BUI BN
ROCHE H
ADENIS L
CATY A
BLIJHAM GH
DEWEWEIRE A
COIFFIER B
SOTTO JJ
VANHEUKELOM LS
TAGNON A
SLEE PHTJ
KROEKS MVAM
RAVEZ P
CUPISSOL D
KEIZER HJ
BRUNNER K
CALVERT AH
YERNAULT JC
LIBERT P
BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
Authors:
WISHART GC
BISSETT D
PAUL J
JODRELL D
HARNETT A
HABESHAW T
KERR DJ
MACHAM MA
SOUKOP M
LEONARD RCF
KNEPIL J
KAYE SB
Citation: Gc. Wishart et al., QUINIDINE AS A RESISTANCE MODULATOR OF EPIRUBICIN IN ADVANCED BREAST-CANCER - MATURE RESULTS OF A PLACEBO-CONTROLLED RANDOMIZED TRIAL, Journal of clinical oncology, 12(9), 1994, pp. 1771-1777
Authors:
PRESCOTT RJ
LEONARD RCF
ALLAN NC
ANGUS B
BARRETT A
DAS SN
DAWSON AA
HEPPLESTON A
LESSELLS AM
LUCIE NP
LUCRAFT HH
MACKIE MJ
MACLAREN KS
MATHESON LM
PARKER AC
PROCTOR SJ
SARKAR TK
SOUKOP M
STEWARD WP
WHITE JM
Citation: Rj. Prescott et al., PILOT-STUDY AND RANDOMIZED TRIAL OF MITOXANTRONE AND IFOSFAMIDE FOR RELAPSED NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 11(1-2), 1993, pp. 111-114
Authors:
CAMERON DA
LEONARD RCF
MAO JH
PRESCOTT RJ
ALLAN NC
BARRETT A
DAS SN
DAWSON AA
HEPPLESTON A
LENNARD AL
LEONARD RCF
LESSELLS AM
LUCIE NP
LUCRAFT HH
MACKIE MJ
MACLAREN KS
MATHESON LM
PARKER AC
PRESCOTT RJ
PROCTOR SJ
ROBERTSON AG
SARKAR TK
SOUKOP M
STEWARD WP
TANSEY PJ
WHITE JM
Citation: Da. Cameron et al., IDENTIFICATION OF PROGNOSTIC GROUPS IN FOLLICULAR LYMPHOMA, Leukemia & lymphoma, 10(1-2), 1993, pp. 89-99
Authors:
AAPRO M
PIGUET D
GIGER K
BAUER J
HAEFLIGER JM
BREMER K
CALS L
CATTAN A
CLAVEL M
CZYGAN P
DEARNALEY D
DIEHL V
HARJUNG M
HARPER P
ILLIGER H
KAYE S
KEIZER HJ
KERBRAT P
KONIG HJ
MONCUQUET P
DEBESANCON C
NAMER M
NOBEL A
NORTIER JWR
OBERLING F
PLAGNE R
REICHLE A
RIVIERE A
SOUKOP M
VEENHOF CHN
ZYLBERAIT D
HUNTER B
Citation: M. Aapro et al., THE ANTIEMETIC EFFICACY AND SAFETY OF GRANISETRON COMPARED WITH METOCLOPRAMIDE PLUS DEXAMETHASONE IN PATIENTS RECEIVING FRACTIONATED CHEMOTHERAPY OVER 5 DAYS, Journal of cancer research and clinical oncology, 119(9), 1993, pp. 555-559
Authors:
FORREST E
GALLACHER SJ
HADLEY D
SOUKOP M
BOYLE IT
Citation: E. Forrest et al., CENTRAL-NERVOUS-SYSTEM HISTIOCYTOSIS-X - IMAGING AND RESPONSES TO CHEMOTHERAPY, Scottish Medical Journal, 38(5), 1993, pp. 148-149